HENAN LINGRUI PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.85 CNY | -0.84% |
|
-1.82% | +45.24% |
| May. 13 | Lingrui Pharma Gets Green Light to Market Type 2 Diabetes Drug | MT |
| Apr. 25 | Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Alternative Medicine
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.94B | - | - | ||||
| 6.26B | ||||||
| 4.49B | ||||||
| 3.29B | - | - | ||||
| 3.12B | ||||||
| 2.5B | - | - | - | - | - |
